Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2026-01-02 @ 7:08 AM
Study NCT ID:
NCT02231866
Status:
COMPLETED
Last Update Posted:
2018-07-05
First Post:
2014-09-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08-27
Start Date Type:
None
Primary Completion Date:
2017-04-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-05
Completion Date Type:
ACTUAL
First Submit Date:
2014-09-03
First Submit QC Date:
None
Study First Post Date:
2014-09-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-03
Last Update Post Date:
2018-07-05
Last Update Post Date Type:
ACTUAL